A cross border network is a real advantage when one is looking to tap a global market. This is where newcomers and entrepreneurs established in Israel can find a forum to share their experience and knowledge.
& Business Angel
Jeremie Berrebi is a French-Israeli entrepreneur and businessman,he is a co-founder of Kima Ventures & active in the Venture Capital, Private Equity & technology industries with more than 360 investments to date.In May 2015, Jeremie Berrebi announced his departure from Kima Ventures, the launch of Magical Capital, advising Family offices and corporates on their investments, acquisitions and digital transformation and joined the LetterOne Technology advisory board.
Prof. Max Herzberg PhD, Serial
Entrepreneur in Biotech. Academy: Part of the first team to develop Genetic
Engineering at Stanford (USA), Tel Aviv and Bar Ilan Universities. Industry:
one of the founder of the Biotech industry in Israel, a co-chair at Pasteur
Incubator in Paris founding/cofounding 7 companies in Israel of which 2 are
traded on Nasdaq. Also a winemaker at Herzberg Winery.
Founder & CEO
Born in Paris and holding a degree from ESCP Europe, Michael Golan started his career in the Rothschild banks in Paris. He then worked for Iliad (headquarter of the internet operator Free) as the chief executive. In 2011, with Golan Telecom, he picks up the 5th israeli mobile phone licence. When the company starts operating in May 2012, it sets off an intense price war - hitherto unprecedented in Israel. By 2015 Golan Telephone had 10% of the Israeli mobile phone market with more than 855,000 subscribers.
Nazareth Business Incubator Center & Accelerator,
NBIC’s mission is to “transform and stimulate the Arab/Israeli economy” through
Tech-entrepreneurship ecosystem by developing partnerships and collaborations
with leading organizations from the private and public sector, and to assure
real and substantial social impact.
Didier has co-founded and held key positions at several innovative medical device companies in Israel. He currently serves as the CEO of NLT SPINE, and previously co-founded and managed of IceCure Medical (TASE: ICCM). Prior to that, he was Head of Business Development at SurgiVision, and Partner- Life Sciences at Cukierman & Co. Investment House. Didier hold an Engineering degree from AgroSup Dijon (France), a Mastère degree from ESCP Europe (France) and a joint Executive MBA from Kellogg and Recanati schools of management (Israel and the USA).
VP Generic R&D et InnoTech
Born in Paris and graduated from the ECP school, Elisabeth Kogan leads the global Generic R&D department of TEVA. Her team develops with success the generic drugs brough to market on which TEVA built its success. Elisabeth Kogan also leads the development of new technologies in order to improve the way drugs are used.